![Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients. - Abstract - Europe PMC Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4896346/bin/i0018-5787-51-5-376-f01.jpg)
Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients. - Abstract - Europe PMC
![PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eecfb8454c29cf58fbd54d7b4003fa7804f10e62/3-Table1-1.png)
PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar
![Evaluating the Effect of High Dose Versus Low Dose Heparin in Peripherally Inserted Central Catheter in Very Low Birth Weight Infants | Iranian Journal of Pediatrics | Full Text Evaluating the Effect of High Dose Versus Low Dose Heparin in Peripherally Inserted Central Catheter in Very Low Birth Weight Infants | Iranian Journal of Pediatrics | Full Text](https://services.brieflands.com/cdn/serve/3144e/4f01e5bd0f3e2952c4edcc0420d1f587618123d2/ijp-28-3-60800-i001-preview.png)
Evaluating the Effect of High Dose Versus Low Dose Heparin in Peripherally Inserted Central Catheter in Very Low Birth Weight Infants | Iranian Journal of Pediatrics | Full Text
![PDF) High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial | Jan Hoorntje - Academia.edu PDF) High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial | Jan Hoorntje - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/41700371/mini_magick20190218-10415-1wat1ur.png?1550547656)
PDF) High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial | Jan Hoorntje - Academia.edu
![Gregg W. Stone MD on Twitter: "1/ BRIGHT-4 tweetorial. 6 large RCTs have compared bivalirudin vs heparin during primary PCI in STEMI w/varying results (slide). The 2 best regimens (bival with a Gregg W. Stone MD on Twitter: "1/ BRIGHT-4 tweetorial. 6 large RCTs have compared bivalirudin vs heparin during primary PCI in STEMI w/varying results (slide). The 2 best regimens (bival with a](https://pbs.twimg.com/media/Fg6_VAvXgAAIK4s.png:large)
Gregg W. Stone MD on Twitter: "1/ BRIGHT-4 tweetorial. 6 large RCTs have compared bivalirudin vs heparin during primary PCI in STEMI w/varying results (slide). The 2 best regimens (bival with a
![Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/asset/787fb81a-bc5b-47fc-8dbc-5e3808361cd0/gr1.jpg)
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet
![Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave](https://www.medwave.cl/medios/medwave/SuplEpis3/6320/fg01_6320EN.jpg)
Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave
![Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1989/nejm_1989.320.issue-6/nejm198902093200604/20130822/images/img_medium/nejm198902093200604_t3.jpeg)
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM
![PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eecfb8454c29cf58fbd54d7b4003fa7804f10e62/4-Table2-1.png)
PDF] High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. | Semantic Scholar
![Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1989/nejm_1989.320.issue-6/nejm198902093200604/20130822/images/img_medium/nejm198902093200604_t2.jpeg)
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction | NEJM
![Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients - Jeffrey Beall, Ashley Woodruff, Carolyn Hempel, Margaret Wovkulich, Kimberly Zammit, 2016 Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients - Jeffrey Beall, Ashley Woodruff, Carolyn Hempel, Margaret Wovkulich, Kimberly Zammit, 2016](https://journals.sagepub.com/cms/10.1310/hpj5105-376/asset/images/large/10.1310_hpj5105-376-fig1.jpeg)